A safe contraceptive method for women of reproductive age with obesity

Aim. The purpose of this study is to determine the safety of using a drospirenone-containing combinedoral contraceptive (СOC) in overweight/obese women of reproductive age.Material and methods. The study included 65 women of reproductive age who were prescribed OC with30 µg of ethinyl estradiol and 3 mg of drospirenone for 3 months for therapeutic and preventive purposes.The main parameters evaluated were lipid and carbohydrate metabolism.Results. According to the results of the study, a favorable effect of low-dose COCs on body weight and lipidprofile was revealed without significant changes in carbohydrate metabolism.Conclusion. СOC may be recommended for overweight/obese patients to control fertility in the postpartum period.

Перевод пока недоступен